Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion

  1. Stevenson, J.P.
  2. DeMaria, D.
  3. Sludden, J.
  4. Kaye, S.B.
  5. Paz-Ares, L.
  6. Grochow, L.B.
  7. McDonald, A.
  8. Selinger, K.
  9. Wissel, P.
  10. O'Dwyer, P.J.
  11. Twelves, C.
Aldizkaria:
Annals of Oncology

ISSN: 0923-7534

Argitalpen urtea: 1999

Alea: 10

Zenbakia: 3

Orrialdeak: 339-344

Mota: Artikulua

DOI: 10.1023/A:1008313011289 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus